DxCG To Serve on Population Health Impact Institute's Grant Advisory Panel; Senior Researcher Will Advise on Disease Management Evaluation Project.BOSTON Boston, town, England Boston, town (1991 pop. 26,495), E central England, on the Witham River. Boston's fame as a port dates from the 13th cent., when it was a Hanseatic port trading wool and wine. Having recovered from a decline in the 18th and 19th cent. -- DxCG(R), Inc, the leading provider of predictive modeling software for health care organizations, announced today that Anju Joglekar, PhD, Senior Research Associate, will serve on the Population Health Impact (PHI phi n. Symbol  The 21st letter of the Greek alphabet.PHI, n See health information, protected. ) Institute's Grant Advisory Panel (GAP) for a disease management project entitled en·ti·tle tr.v. en·ti·tled, en·ti·tling, en·ti·tles 1. To give a name or title to. 2. To furnish with a right or claim to something: , "Quality of Methods & Strength of Evidence for Disease Management Evaluation," and funded by the Health Industry Forum at Brandeis University Brandeis University, at Waltham, Mass.; coeducational; chartered and opened 1948. Although Brandeis was founded by members of the American Jewish community, the university operates as an independent, nonsectarian institution. . The GAP will help the PHI Institute investigators provide "real world" guidance for communicating disease management evaluation principles and helping non-experts improve the quality and credibility of evaluations performed. Another panel in the project, the "Delphi Panel," is charged with rating 25 recent peer-reviewed disease management studies on the basis of their methodology and strength of evidence using the Institute's Five Evaluation Principles (http://www.phiinstitute.org/expert.html). Dr. Thomas Wilson Thomas Wilson is the name of a number of different people:
"The evaluation and efficacy of disease management is one of the toughest challenges for health plans," "I'm excited to be a part of this project that helps improve and strengthen disease management methods, said Anju Joglekar, senior researcher at DxCG. Since joining DxCG in 2004, Anju Joglekar has worked on creating models for targeting disease and case management interventions. She has also been involved in the application of risk adjustment in disease management evaluation. Earlier in her career, Joglekar was Vice President of Statistical Services at Medical Scientists. About DxCG, Inc. DxCG, an ISO (1) See ISO speed. (2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI. business, promotes fair and efficient health care by providing software solutions to more accurately plan, budget and evaluate health care management programs. DxCG has more than 250 clients, in the U.S. and abroad. The company's Diagnostic Cost Group (DCG DCG - Definite Clause Grammar ) and RxGroups(R) predictive models are used to negotiate health-based payments, identify opportunities for disease management, profile physicians and evaluate managed care programs. Recognized by leading independent researchers as the most proven models available, DxCG's methodologies are used by the federal government to set payment rates for Medicare Medicare, national health insurance program in the United States for persons aged 65 and over and the disabled. It was established in 1965 with passage of the Social Security Amendments and is now run by the Centers for Medicare and Medicaid Services. . For more information, visit the company's web site at www.dxcg.com. About the Population Health Impact Institute. The Population Health Impact (PHI) Institute is a non-profit organization A non-profit organization (abbreviated "NPO", also "non-profit" or "not-for-profit") is a legally constituted organization whose primary objective is to support or to actively engage in activities of public or private interest without any commercial or monetary profit purposes. founded in 2004 to promote and provide credible, transparent, and replicable impact evaluations of defined population health programs (e.g., wellness, health promotion, payment for provider performance, disease management, case management, medical management, etc.). See www.PHIinstitute.org or Dr. Wilson at 513.289.3743 for more information. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion